Oncternal Therapeutics(ONCT) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results SAN DIEGO, May 9, 2024 -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today provided a business update and reported first quarter 2024 financial results. "We are encouraged by the fast pace of execution for our clinical programs, and we are looking forward to important clinical data readouts in the ...